Amrisha Bhosle

Metagenomic assessment of gut microbial communities and risk of severe COVID-19.

Lai P, Nguyen L, Okin D, Drew D, Battista V, Jesudasen S, Kuntz T, Bhosle A, Thompson K, Reinicke T, Lo CH, Woo J, Caraballo A, Berra L, Vieira J, Huang CY, Adhikari UD, Kim M, Sui HY, Magicheva-Gupta M, McIver L, Goldberg M, Kwon D, Huttenhower C, Chan A.

Res Sq. 2022 Jun 07. PMID: 35677075

Discovery of bioactive microbial gene products in inflammatory bowel disease.

Zhang Y, Bhosle A, Bae S, McIver LJ, Pishchany G, Accorsi EK, Thompson KN, Arze C, Wang Y, Subramanian A, Kearney SM, Pawluk A, Plichta DR, Rahnavard A, Shafquat A, Xavier RJ, Vlamakis H, Garrett WS, Krueger A, Huttenhower C, Franzosa EA.

Nature. 2022 06. 606(7915):754-760. PMID: 35614211

A Strategic Target Rescues Trimethoprim Sensitivity in Escherichia coli.

Bhosle A, Datey A, Chandrasekharan G, Singh D, Chakravortty D, Chandra N.

iScience. 2020 Apr 24. 23(4):100986. PMID: 32240953

Structural analysis of dihydrofolate reductases enables rationalization of antifolate binding affinities and suggests repurposing possibilities.

Bhosle A, Chandra N.

FEBS J. 2016 Mar. 283(6):1139-67. PMID: 26797763

MS3ALIGN: an efficient molecular surface aligner using the topology of surface curvature.

Shivashankar N, Patil S, Bhosle A, Chandra N, Natarajan V.

BMC Bioinformatics. 2016 Jan 12. 17:26. PMID: 26753741

Complete Genome Sequences of an Escherichia coli Laboratory Strain and Trimethoprim-Resistant (TMP32XR) Mutant Strains.

Mohan A, Bhosle A, Chandra N.

Genome Announc. 2015 Dec 10. 3(6). PMID: 26659679